Regulation_NN
of_IN
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
and_CC
cytokine_NN
gene_NN
expression_NN
in_IN
myeloid_JJ
cells_NNS
by_IN
NF-kappa_NN
B_NN
\/_:
Rel_NN
transcription_NN
factors_NNS
._.

CD4_NN
+_CC
macrophages_NNS
in_IN
tissues_NNS
such_JJ
as_IN
lung_NN
,_,
skin_NN
,_,
and_CC
lymph_NN
nodes_NNS
,_,
promyelocytic_JJ
cells_NNS
in_IN
bone_NN
marrow_NN
,_,
and_CC
peripheral_JJ
blood_NN
monocytes_NNS
serve_VBP
as_IN
important_JJ
targets_NNS
and_CC
reservoirs_NNS
for_IN
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
-LRB-_-LRB-
HIV-1_NN
-RRB-_-RRB-
replication_NN
._.

HIV-1-infected_JJ
myeloid_JJ
cells_NNS
are_VBP
often_RB
diminished_VBN
in_IN
their_PRP$
ability_NN
to_TO
participate_VB
in_IN
chemotaxis_NN
,_,
phagocytosis_NN
,_,
and_CC
intracellular_JJ
killing_NN
._.

HIV-1_NN
infection_NN
of_IN
myeloid_JJ
cells_NNS
can_MD
lead_VB
to_TO
the_DT
expression_NN
of_IN
surface_NN
receptors_NNS
associated_VBN
with_IN
cellular_JJ
activation_NN
and\/or_CC
differentiation_NN
that_WDT
increase_VBP
the_DT
responsiveness_NN
of_IN
these_DT
cells_NNS
to_TO
cytokines_NNS
secreted_VBN
by_IN
neighboring_VBG
cells_NNS
as_RB
well_RB
as_IN
to_TO
bacteria_NNS
or_CC
other_JJ
pathogens_NNS
._.

Enhancement_NN
of_IN
HIV-1_NN
replication_NN
is_VBZ
related_JJ
in_IN
part_NN
to_TO
increased_VBN
DNA-binding_JJ
activity_NN
of_IN
cellular_JJ
transcription_NN
factors_NNS
such_JJ
as_IN
NF-kappa_NN
B_NN
._.

NF-kappa_NN
B_NN
binds_VBZ
to_TO
the_DT
HIV-1_NN
enhancer_NN
region_NN
of_IN
the_DT
long_JJ
terminal_JJ
repeat_NN
and_CC
contributes_VBZ
to_TO
the_DT
inducibility_NN
of_IN
HIV-1_NN
gene_NN
expression_NN
in_IN
response_NN
to_TO
multiple_JJ
activating_VBG
agents_NNS
._.

Phosphorylation_NN
and_CC
degradation_NN
of_IN
the_DT
cytoplasmic_JJ
inhibitor_NN
I_NN
kappa_NN
B_NN
alpha_NN
are_VBP
crucial_JJ
regulatory_JJ
events_NNS
in_IN
the_DT
activation_NN
of_IN
NF-kappa_NN
B_NN
DNA-binding_JJ
activity_NN
._.

Both_CC
N_NN
-_:
and_CC
C-terminal_JJ
residues_NNS
of_IN
I_NN
kappa_NN
B_NN
alpha_NN
are_VBP
required_VBN
for_IN
inducer-mediated_JJ
degradation_NN
._.

Chronic_JJ
HIV-1_NN
infection_NN
of_IN
myeloid_JJ
cells_NNS
leads_VBZ
to_TO
constitutive_JJ
NF-kappa_NN
B_NN
DNA-binding_JJ
activity_NN
and_CC
provides_VBZ
an_DT
intranuclear_JJ
environment_NN
capable_JJ
of_IN
perpetuating_VBG
HIV-1_NN
replication_NN
._.

Increased_VBN
intracellular_JJ
stores_NNS
of_IN
latent_JJ
NF-kappa_NN
B_NN
may_MD
also_RB
result_VB
in_IN
rapid_JJ
inducibility_NN
of_IN
NF-kappa_NN
B-dependent_JJ
cytokine_NN
gene_NN
expression_NN
._.

In_IN
response_NN
to_TO
secondary_JJ
pathogenic_JJ
infections_NNS
or_CC
antigenic_JJ
challenge_NN
,_,
cytokine_NN
gene_NN
expression_NN
is_VBZ
rapidly_RB
induced_VBN
,_,
enhanced_VBN
,_,
and_CC
sustained_JJ
over_IN
prolonged_JJ
periods_NNS
in_IN
HIV-1-infected_JJ
myeloid_JJ
cells_NNS
compared_VBN
with_IN
uninfected_JJ
cells_NNS
._.

Elevated_JJ
levels_NNS
of_IN
several_JJ
inflammatory_JJ
cytokines_NNS
have_VBP
been_VBN
detected_VBN
in_IN
the_DT
sera_NN
of_IN
HIV-1-infected_JJ
individuals_NNS
._.

Secretion_NN
of_IN
myeloid_JJ
cell-derived_JJ
cytokines_NNS
may_MD
both_CC
increase_VB
virus_NN
production_NN
and_CC
contribute_VB
to_TO
AIDS-associated_JJ
disorders_NNS
._.

